Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

About the Cover

October 07, 2019; Volume 14,Issue 10

Cover image

Cover image expansion

On the Cover

What’s the diagnosis?

A 41-year-old male with type 2 diabetes mellitus taking dapagliflozin, one of sodium-glucose cotransporter-2 (SGLT2) inhibitors, 5 mg daily, was admitted to our hospital, with oliguric acute kidney injury. He reported no history of being exposed to IV contrast or other agents. Ultrasonography scans revealed no evidence of urinary tract obstruction, heart failure, or cirrhosis. Laboratory examination showed blood glucose of 74 mg/dL, hemoglobin A1c of 6.1 %, and serum creatinine of 3.0 mg/dL (baseline 1.1 mg/dL). Urinalysis was positive for glucose (+4) with osmolality of 836 mOsm/kg, and negative for protein, occult blood, crystals, or sediment abnormalities.

A histological preparation of kidney revealed focal isometric vacuolization in the proximal tubules (Figure 1) and pale periodic acid-Schiff (PAS)-positive glycogen accumulation within the cytoplasm of epithelial cells (Figure 2). Electron microscopy showed cytoplasmic vacuoles in the proximal tubules with preserved brush borders (Figure 3). A diagnosis of osmotic nephropathy, most likely due to dapagliflozin, was made. His physical status and serum creatinine level returned to normal after normal saline infusion and dapagliflozin discontinuation.

Osmotic nephropathy describes structural changes with vacuolization and swelling of the proximal tubules that obstruct urine flow, resulting in oliguric acute kidney injury. The known agents that cause osmotic nephropathy, include mannitol, contrast media and intravenous immunoglobulin. The similar lesion was first described in patients with poorly controlled diabetes or diabetic ketoacidosis in the late 1800s. However, it has been rarely seen for nearly a century, after the advent of insulin therapy and subsequent glucose lowering agents. Although it is premature to conclude that SGLT2 inhibitors caused osmotic nephropathy because of underlying diabetes and being based on a single case, and therefore needs further evaluation, this lesion could be associated with SGLT2 inhibitors, since these agents particularly increase the amount of urinary glucose, even on the condition of euglycemia, resulting in severe hyperglycosuria, that imposes a similar situation with the morphogenesis of osmotic nephropathy.

(Images and text were provided by Masayuki Yamanouchi, MD, MPH, Shun Watanabe, MD, Junichi Hoshino, MD, Yoshifumi Ubara, MD, Toranomon Hospital, Tokyo, Japan: Yutaka Yamaguchi, MD, Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan: and Kenichi Ohashi, MD, Department of Pathology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan)

Back to top
PreviousNext

In this issue

Clinical Journal of the American Society of Nephrology: 14 (10)
Clinical Journal of the American Society of Nephrology
Vol. 14, Issue 10
October 07, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
View Selected Citations (0)

Jump to

  • Patient Voice
  • Editorials
  • Original Articles
    • Acute Kidney Injury and ICU Nephrology
    • Chronic Kidney Disease
    • Glomerular and Tubulointerstitial Diseases
    • Maintenance Dialysis
    • Transplantation
  • Research Letter
  • Erratum
  • Kidney Case Conference: How I Treat
  • Perspectives
  • Feature
  • Most Read
Loading
  • Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration
  • Mitigating Risk of COVID-19 in Dialysis Facilities
  • COVID-19 and the Inpatient Dialysis Unit
  • COVID-19 in Patients with Kidney Disease
  • Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
More...

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire